CC

Caxton Corporation Portfolio holdings

AUM $9.85M
This Quarter Return
+8.66%
1 Year Return
+26.35%
3 Year Return
+409.06%
5 Year Return
+527.59%
10 Year Return
+11,054.45%
AUM
$16.6M
AUM Growth
+$16.6M
Cap. Flow
-$10.2M
Cap. Flow %
-61.44%
Top 10 Hldgs %
98.81%
Holding
16
New
4
Increased
–
Reduced
3
Closed
1

Top Buys

1
GLD icon
SPDR Gold Trust
GLD
$283K
2
CRDF icon
Cardiff Oncology
CRDF
$57.7K
3
IKT icon
Inhibikase Therapeutics
IKT
$53.3K
4
CBIO
Crescent Biopharma, Inc. Common Stock
CBIO
$50.9K

Top Sells

1
XERS icon
Xeris Biopharma Holdings
XERS
$10.5M
2
ABVX
Abivax
ABVX
$131K
3
SPY icon
SPDR S&P 500 ETF Trust
SPY
$25.8K
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
$8.16K

Sector Composition

1 Healthcare 85.27%
2 Financials 3.09%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
XERS icon
1
Xeris Biopharma Holdings
XERS
$1.26B
$6.83M 41.06%
2,015,157
-3,098,191
-61% -$10.5M
RZLT icon
2
Rezolute
RZLT
$619M
$6.46M 38.85%
1,318,967
– –
SPY icon
3
SPDR S&P 500 ETF Trust
SPY
$658B
$1.65M 9.94%
2,823
-44
-2% -$25.8K
BRK.B icon
4
Berkshire Hathaway Class B
BRK.B
$1.09T
$514K 3.09%
1,133
-18
-2% -$8.16K
GLD icon
5
SPDR Gold Trust
GLD
$107B
$283K 1.7%
+1,169
New +$283K
MNMD icon
6
MindMed
MNMD
$676M
$237K 1.43%
34,073
– –
BCAX
7
Bicara Therapeutics Inc. Common Stock
BCAX
$651M
$191K 1.15%
10,941
– –
LXEO icon
8
Lexeo Therapeutics
LXEO
$259M
$117K 0.71%
17,851
– –
KYTX icon
9
Kyverna Therapeutics
KYTX
$160M
$86K 0.52%
22,981
– –
CMPX icon
10
Compass Therapeutics
CMPX
$483M
$63K 0.38%
43,465
– –
CRDF icon
11
Cardiff Oncology
CRDF
$140M
$57.7K 0.35%
+13,287
New +$57.7K
IKT icon
12
Inhibikase Therapeutics
IKT
$134M
$53.3K 0.32%
+16,393
New +$53.3K
CBIO
13
Crescent Biopharma, Inc. Common Stock
CBIO
$200M
$50.9K 0.31%
+203,578
New +$50.9K
CNTX icon
14
Context Therapeutics
CNTX
$75.4M
$19.3K 0.12%
18,403
– –
ACET icon
15
Adicet Bio
ACET
$59.9M
$16.8K 0.1%
17,488
– –
ABVX
16
Abivax
ABVX
$6.12B
– –
-11,365
Closed -$131K